Vandenbark A A, Celnik B, Vainiene M, Miller S D, Offner H
Neuroimmunology Research, Veterans Affairs Medical Center, Portland, OR 97201, USA.
J Immunol. 1995 Dec 15;155(12):5861-7.
Mechanisms of adult tolerance induced by injecting myelin Ag/ECDI (ethyl carbodiimide)-coupled splenocytes (Ag-SPL) were evaluated in Lewis rat experimental autoimmune encephalomyelitis (EAE). Rats could be tolerized against the major encephalitogenic epitope of guinea pig basic protein (Gp-BP), residues 72-89, using either S72-89-SPL or crude spinal cord homogenate (SCH)-SPL. In contrast to lymph node responses that were not affected significantly, the proliferation responses of blood T cells were markedly inhibited at the peak of EAE and during the recovery period to both Gp-BP and S72-89, but not to purified protein derivative (PPD), demonstrating Ag-specific tolerance. Tolerance induction reduced the number of infiltrating spinal cord (SC) cells, especially recruited CD45RC+ cells, as well as SC proliferation responses to S72-89 throughout the course of EAE. In contrast, SC response to PPD was increased at onset of EAE, but later during recovery the PPD response was also decreased compared with control rats. Tolerance induced by S72-89-SPL in blood and SC T cells could be reversed by incubation in IL-2, in accordance with an anergy model. BP-specific T cells preincubated in vitro with Gp-BP-SPL were rendered unresponsive to Gp-BP or S72-89, compared with the same T cells preincubated with histone (Hist)-SPL that remained Ag responsive. Consistent with an anergy model, preincubation with BP-SPL+IL-2 partially prevented tolerance induction to BP. T cells tolerized in vitro to BP-SPL induced milder EAE with delayed onset compared with control-tolerized T cells that produced lethal disease. These results demonstrate the efficacy of myelin Ag-coupled SPL in preventing EAE by selective tolerization of encephalitogenic T cells through a partially reversible anergy-induction mechanism.
在Lewis大鼠实验性自身免疫性脑脊髓炎(EAE)中,评估了注射髓磷脂抗原/碳二亚胺乙酯(ECDI)偶联脾细胞(Ag-SPL)诱导成年大鼠产生耐受性的机制。使用S72-89-SPL或粗脊髓匀浆(SCH)-SPL,大鼠可对豚鼠碱性蛋白(Gp-BP)的主要致脑炎性表位(第72 - 89位氨基酸残基)产生耐受性。与未受显著影响的淋巴结反应不同,在EAE高峰期和恢复期,血液T细胞对Gp-BP和S72-89的增殖反应均受到明显抑制,但对纯化蛋白衍生物(PPD)无抑制,表明存在抗原特异性耐受性。诱导耐受性减少了浸润脊髓(SC)的细胞数量,尤其是募集的CD45RC+细胞,以及在EAE整个病程中SC对S72-89的增殖反应。相比之下,在EAE发病时SC对PPD的反应增强,但在恢复期后期,与对照大鼠相比,PPD反应也降低。根据无反应性模型,S72-89-SPL在血液和SC T细胞中诱导的耐受性可通过在IL-2中孵育而逆转。与预先用组蛋白(Hist)-SPL孵育且仍对抗原反应的相同T细胞相比,体外预先用Gp-BP-SPL孵育的BP特异性T细胞对Gp-BP或S72-89无反应。与无反应性模型一致,预先用BP-SPL + IL-2孵育可部分阻止对BP的耐受性诱导。与产生致命疾病的对照耐受T细胞相比,体外对BP-SPL耐受的T细胞诱导的EAE症状较轻且发病延迟。这些结果证明了髓磷脂抗原偶联的SPL通过部分可逆的无反应性诱导机制选择性地使致脑炎性T细胞耐受,从而预防EAE的有效性。